Mark Laible
Impact in
-
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
Papers in
-
- Gene expression and cancer classification 4
- Molecular Biology Techniques and Applications 3
- Advanced Biosensing Techniques and Applications 2
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Kajohn Boonrod (2 shared papers)Ralph M. Wirtz (10 shared papers)Kornelia Schlombs (9 shared papers)Sebastian Eidt (6 shared papers)Uğur Şahin (9 shared papers)Elke Veltrup (2 shared papers)Peter Altevogt (2 shared papers)Arndt Hartmann (3 shared papers)
- Journals
- BMC Cancer (3 papers)Cancer Research (3 papers)Journal of Visualized Experiments (2 papers)Oncotarget (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyItalySwitzerland
In The Last Decade
Mark Laible
18 papers receiving 409 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 88
- Oncology 87
- Molecular Biology 180
- Surgery 77
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Mark Laible
This map shows the geographic impact of Mark Laible's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Laible with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Laible more than expected).
Fields of papers citing papers by Mark Laible
This network shows the impact of papers produced by Mark Laible. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Laible. The network helps show where Mark Laible may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Laible, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 74 | |
| 2 | 2017 | 67 | |
| 3 | 2016 | 42 | |
| 4 | 2009 | 31 | |
| 5 | 2016 | 28 | |
| 6 | 2016 | 27 | |
| 7 | 2016 | 26 | |
| 8 | 2017 | 23 | |
| 9 | 2013 | 23 | |
| 10 | 2023 | 18 | |
| 11 | 2017 | 14 | |
| 12 | 2008 | 13 | |
| 13 | 2019 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2018 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2015 | 1 | |
| 19 | 2019 | 0 | |
| 20 | 2025 | 0 |
About Mark Laible
Mark Laible is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 417 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Gene expression and cancer classification (4 papers), Molecular Biology Techniques and Applications (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Prostate Cancer Treatment and Research (2 papers), Animal Genetics and Reproduction (2 papers), Urinary and Genital Oncology Studies (2 papers) and Advanced Biosensing Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (88 citations), Oncology (87 citations), Molecular Biology (180 citations), Surgery (77 citations) and Pulmonary and Respiratory Medicine (45 citations). Mark Laible has collaborated with scholars based in Germany, Italy and Switzerland. Frequent co-authors include Kajohn Boonrod, Ralph M. Wirtz, Kornelia Schlombs, Sebastian Eidt, Uğur Şahin, Elke Veltrup, Peter Altevogt, Arndt Hartmann, Holger Sültmann and Sotiris Lakis. Their work appears in journals such as BMC Cancer, Cancer Research, Journal of Visualized Experiments, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.